StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Penumbra, Inc.
NYSE:PEN
Sector
Location
Market Cap
USD 9.60 B
Share Price
USD 244.39
Avg Daily Volume
520,605
Change (1 day)
-1.38%
Change (1 year)
37.30%
Change (YTD)
2.91%
Penumbra, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 179.16 M
Penumbra, Inc. Operating Cash Flow is USD 179.16 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 46.25% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Penumbra, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 122.50 M, a -422.21% change year over year.
-
Penumbra, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -38.02 M, a -296.41% change year over year.
-
Penumbra, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 19.36 M, a -146.43% change year over year.
-
Penumbra, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -41.69 M, a -282.85% change year over year.
Competitors
Boston Scientific Corporation
USD 102.96
BSX
+0.55
0.54%
Siemens Healthineers AG
USD 55.55
SHL.DE
+0.55
1.00%
Edwards Lifesciences Corporation
USD 77.19
EW
+0.80
1.05%
GE HealthCare Technologies Inc.
USD 75.51
GEHC
+0.31
0.41%
DexCom, Inc.
USD 84.87
DXCM
+1.11
1.32%
Natera, Inc.
USD 161.75
NTRA
+3.27
2.06%
Laboratory Corporation of America Holdings
USD 259.07
LH
+1.62
0.63%
Baxter International Inc.
USD 29.81
BAX
-0.85
-2.77%
Hologic, Inc.
USD 65.85
HOLX
+0.95
1.46%
Fisher & Paykel Healthcare Corporation Limited
USD 22.12
FPH.NZ
-0.04
-0.18%
Exact Sciences Corporation
USD 55.31
EXAS
+1.77
3.31%
ConvaTec Group Plc
USD 3.58
CTEC.L
+0.02
0.57%
Hangzhou Tigermed Consulting Co., Ltd.
USD 5.94
3347.HK
+0.38
6.75%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 7.74
300832.SZ
+0.07
0.86%
APT Medical Inc.
USD 40.95
688617.SS
+0.64
1.58%
Lantheus Holdings, Inc.
USD 83.49
LNTH
+1.08
1.31%
DiaSorin S.p.A.
USD 105.26
DIA.MI
+0.71
0.68%
Carl Zeiss Meditec AG
USD 61.47
AFX.DE
+0.27
0.44%
Teleflex Incorporated
USD 118.93
TFX
-0.75
-0.63%
iRhythm Technologies, Inc.
USD 132.88
IRTC
-1.75
-1.30%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Boston Scientific Corporation
USD 102.96
BSX
+0.55
0.54%
Siemens Healthineers AG
USD 55.55
SHL.DE
+0.55
1.00%
Edwards Lifesciences Corporation
USD 77.19
EW
+0.80
1.05%
GE HealthCare Technologies Inc.
USD 75.51
GEHC
+0.31
0.41%
DexCom, Inc.
USD 84.87
DXCM
+1.11
1.32%
Natera, Inc.
USD 161.75
NTRA
+3.27
2.06%
Laboratory Corporation of America Holdings
USD 259.07
LH
+1.62
0.63%
Baxter International Inc.
USD 29.81
BAX
-0.85
-2.77%
Hologic, Inc.
USD 65.85
HOLX
+0.95
1.46%
Fisher & Paykel Healthcare Corporation Limited
USD 22.12
FPH.NZ
-0.04
-0.18%
Exact Sciences Corporation
USD 55.31
EXAS
+1.77
3.31%
ConvaTec Group Plc
USD 3.58
CTEC.L
+0.02
0.57%
Hangzhou Tigermed Consulting Co., Ltd.
USD 5.94
3347.HK
+0.38
6.75%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 7.74
300832.SZ
+0.07
0.86%
APT Medical Inc.
USD 40.95
688617.SS
+0.64
1.58%
Lantheus Holdings, Inc.
USD 83.49
LNTH
+1.08
1.31%
DiaSorin S.p.A.
USD 105.26
DIA.MI
+0.71
0.68%
Carl Zeiss Meditec AG
USD 61.47
AFX.DE
+0.27
0.44%
Teleflex Incorporated
USD 118.93
TFX
-0.75
-0.63%
iRhythm Technologies, Inc.
USD 132.88
IRTC
-1.75
-1.30%